Peptide sequencing. Disulfide linkages were reduced with dithiothreitol (100 mM) for 1 hour at 56°C after which the resulting free cysteines were alkylated with iodoacetamide (100 mM) for 1 hour at 25°C in pH 7.5 ammonium bicarbonate buffer (50 mM). MALDI-TOF analysis indicated a change in mass of 350.4 after reduction and alkylation which corresponds to approximately six alkylated cysteines. It could be deduced that the native material possessed three disulfide bonds. Peptide digestions were carried out by incubating reduced and alkylated peptide with trypsin (Promega Gold) in pH 8.5 Tris buffer (50 mM) for 18-24 hours at 37 °C, or with GluC (V8 protease, Roche) in pH 8.5 sodium phosphate buffer (50 mM) for 18-24 hours. De novo sequencing: Sequencing was performed by LC-MS/MS on an LC Packings capillary LC system (Dionex) coupled to a QSTAR Pulsar quadrupole TOF mass spectrometer (Applied Biosystems). MS data were acquired using Analyst QS software (Applied Biosystems) for information-dependent acquisition. N2 was used as collision gas and the ionization tip voltage was 2200 V. Edman sequencing: Digested peptides were separated on a Vydac HPLC microbore C18 column (ODS-300, 7 µm, 1 × 50 mm). The peptide fractions were loaded on a precycled glass fiber filter coated with Biobrene and sequenced by the Edman degradation liquid phase method using a Procise cLC-494 (Applied Biosystems) equipped with an on-line 140D Phenylthio-hydantoin analyser (Applied Biosystem). The phenylthiohydantoin amino acid (PTH-aa) derivatives were determined by comparison with standards analyzed at the start of the sequence analysis. CD spectroscopy. Analysis was conducted on a Jasco J-815 CD spectrophotometer. Samples of synthetic, natural, and recombinant helianthamide were diluted in distilled water. Analysis was run from 260 to 190 nm for the natural and synthetic material, and 250 to 190 nm for the recombinant material. The resulting data was analyzed on the Dichroweb server(1). All three data sets were analyzed with CONTIN software using reference sets 4, 7, and SP175(2, 3) . The data of the natural and synthetic material was also analyzed using CDSSTR software with reference sets 4, 7, and SP175. The secondary structural estimates were averaged and presented in Table S1 .
Thiol titration assay.
A solution of thiol titration buffer was prepared (0.2 mM 5,5'-dithiobis-(2-nitrobenzoic acid), 6 M guanidinium chloride, 20 mM HEPES, 1 mM EDTA, pH 7.4). Helianthamide was added to the solution in final protein concentrations ranging from 2 -6 µM(4). The release of 2-nitro-5-thiobenzoate was monitored at 412 nm at 25 ᵒC over the course of 30 minutes. During each measurement, ΔA412 was also measured for the thiol titration buffer to take into account the rate of spontaneous hydrolysis of the DTNB reagent. The experiment was also conducted with BSA, which has one free thiol group, as a positive control.
Disulfide assignment of recombinant material. Intact helianthamide was incubated in 11 M hydrochloric acid at 37 ᵒC for 4 days. The sample was diluted and neutralized before desalting by C18 reverse phase chromatography. The peptide mixture was injected into an Agilent 6460 QQQ LC/MS mass spectrometer. Elution and MS/MS analysis was carried out over a 40 minute period. A script was written to predict all possible fragments for the helianthamide sequence in the event of random hydrolysis and was used to analyze the resulting MS and MS/MS peaks.
Expression of human pancreatic α-amylase.
A detailed protocol for the expression and purification of HPA can be found in the work done by Rydberg et al. (5) Expression was carried out in Pichia pastoris. Colonies were grown in 60 mL BMGY media at 30ᵒC 200 RPM. 20 mL of the overnight culture was added to 600 mL BMGY. After 16 hours the cells were transferred to 300 mL BMMY. After one day 2 mL of 50% methanol was added. The culture was left overnight. The culture supernatant was collected and purified via Phenyl Sepharose and Hitrap Q columns. Deglycosylation was performed with N-glycosidase F.
( His-tag is highlighted in green. The active site mutation of barnase is highlighted in pink. The TEV protease recognition site is highlighted in yellow. Table S1 . Secondary structural analysis of the CD spectra (Fig 1b) 
